Real-Time Insights
Life-Changing Outcomes
An FDA Breakthrough device, "The Tumor Monorail" is a new approach for tracking and treating recurring glioblastoma, one of the deadliest cancers, in real time.
This clinical device is designed to direct migrating tumor cells, which would typically invade healthy tissue, to a controlled area where they can be removed and analyzed during treatment.
*Location of Trial - Duke University Medical Center - North Carolina
